Læknablaðið : fylgirit - 01.08.2003, Qupperneq 11

ABSTRACTS / 27TH NORDIC PSYCHIATRIC CONGRESS I
Course dcscription: Approaches to assessment and risk manage-
ment in anorexia nervosa. Approaches to assessment and risk
management in bulimia nervosa. Aetiology and case conceptualisa-
tion in anorexia/bulimia nervosa. Evidence based treatments for
anorexia/bulimia nervosa
Course methods and material: The course will include a mixture of
seminar-based presentation of theory and evidence with time for
discussion. There will also be some practical based learning and
video demonstrations. The course will also include some fundamen-
tal skills such as how to engage with a case of eating disorders
íntroducing motivational interviewing and enhancement the course
will cover the theoretical and practical application of how models of
behaviour change influence practice. Furthermore this course will
help develop some of the core skills in managing people who are
not ready to change. The basic principles of motivational inter-
viewing will be discussed, demonstrated and enacted. AIso there
will be an introduction as to how to assess case and develop a case
conceptualisation. There will also be an introduction to some of the
principal skills of evidence-based treatments of eating disorders
References
• Schmidt U & Treasure J (1993) Getting Better Bit(e) by Bit(e). A survival kit for
sufferers of bulimia nervosa and binge eating disorder. Psychology Press
• Schmidt U & Treasure J (1997) A clinician's guide to getting better bite by bite.
Psychology Press.
• Treasure J (1997) Anorexia nervosa. A survival guide for sufferers and those
caring for someone with an eating disorder. Psychology Press.
• Hoek H, Treasure JL, Katzman M (1998) Neurobiology of eating Disorders.
Wiley. Chichester
• Szmukler G, Dare C & Treasure JL (1995) Handbook on Eating Disorders.
Wiley. Chichester
Treasure Jl, Schmidt U & Van Furth (2003) Handbook on Eating Disorders.
Wiley. Chichester
Web site www.eatingresearch.com
w-4 Friday 15/8, 14:00-17:45
An eclectic approach to the treatment of personality
disorder
John Livesley, Professor, Department of Psychiatry, University of British Columbia,
2250 Wesbrook Mall, Vancouver, BC, Canada, V6T1W6
This course will discuss the treatment of personality disorder using
a combination of interventions drawn from different approaches.
Emphasis is placed upon treating the general features of persona-
lity disorder rather than specific DSM-III disorders. It is suggested
that personality disorder may be conceptualized as general features
common to all forms of disorder and specific features and psycho-
pathology that vary across individuals and different forms of dis-
order. This suggests a treatment model consisting of general strate-
gies used with all patients throughout treatment and specific inter-
ventions tailored according to patient need, problems that are the
current focus of attention, and stage of treatment. General strate-
gies include establishing and maintaining a consistent framework
for therapy, building and maintaining an effective treatment alli-
ance, and showing a validating process and building motivation.
Specific interventions will be discussed including strategies drawn
from cognitive-behavioral modes of treatment, interpersonal and
psychodynamic therapies, and medication. Strategies for combining
these within an overall treatment framework will be explored.
Pl - Plenary
Pl - 1 Thursday 14/8, 09:00-9:30
Early detection and treatment of psychosis
Mercle Nordentoft, Senior Consultant, PhD, Bispebjerg Hospital, Department of
Psychiatry, Bispebjerg Bakke 23,2400 Copenhagen NV, Denmark. Lone Petersen, Anne
Thorup, Pia Jeppesen.
merete.nordentoft@dadlnel.dk
Background: Schizophrenia spectrum disorders generally strike
during late adolescence or early adulthood and may affect all
aspects of life with far-reaching implications for the individual and
the family. International interest in early psychosis continues to
grow rapidly in both clinical settings and in the growing research
literature. OPUS is the first large randomized controlled trial of
integrated treatment versus standard treatment in first episode
psychosis.
Aim: The aim is to present the evidence of an association between
long duration of untreated psychosis and poor prognosis, and to
present the results of one-year follow-up in the Danish OPUS trial.
Methods: A total of 547 first episode patients with schizophrenia
spectrum disorders were randomly assigned to either integrated
treatment by a multidisciplinary psychosis team (275 patients) or
treatment as usual (272 patients). The integrated treatment con-
sisted of assertive community treatment, psycho-educational multi-
family groups, social skills training and antipsychotic medication.
Standard treatment offered contact with a community mental
health center. Each patient was assessed comprehensively with
SCAN, SAPS, SANS, Social Network Schedule and CSQ at base-
line and after one year by independent researchers.
Results: At one year follow-up data from hospital records was
available for 507 patients, 263 (96 percent) in integrated treatment
and 244 (90 percent) in standard treatment. A total of 419 partici-
pated in follow-up interviews, 227 (83 percent) and 192 (71 percent)
respectively. Patients in integrated treatment had better outcome
concerning positive and negative symptoms and this was not ex-
plained by more patients receiving antipsychotic medication.
Patients in integrated treatment were more satisfied with treat-
ment. More patients in integrated treatment started or continued
education and more lived independently. Fewer patients in inte-
grated treatment had comorbid alcohol or drug abuse at one-year
follow-up (16 percent versus 22 percent), and fewer had been
admitted. Patients in integrated treatment used 61 (mean) bed days
during the first year of follow-up, while patients in standard treat-
ment used 81 (mean) bed days.
Condusion: The integrated treatment improved clinical and social
outcome after one year. Copenhagen and Aarhus municipalities,
where the trial was conducted, have decided to implement the
treatment as standard treatment.
Pl - 2 Thursday 14/8, 09:30-10:00
Neuregulin and the molecular genetics of schizophrenia
Hunncs PéturssonL Hreinn StefánssonL Engilbert SigurðssonL Valgerður Steinjiórs-
dóttirZ, Þórður Sigmundssonl, Jón BrynjólfssonL Steinunn GunnarsdóttirL Ómar Ivars-
LÆKNABLAÐIÐ / FYLGIRIT 48 2003/89 1 1